Alnylam Pharmaceuticals | ALNY - 利息收入

股票价格

311.10

每天变化

-3.70 -1.18%

每月一次

-7.46%

每年

22.70%

Q1 预测

303.95

金融业

USD

USD 4.97B

现金及等价物

USD 1.66B

USD 267.72M

USD 4.05B

USD 1.47B

USD 1.31B

USD 29.4M

USD 145.22M

2.23K

EPS每股收益

USD 1.25

股本和储备

USD 789.18M

USD 829.31M

债务利息支出

USD 129.34M

USD 28.68M

USD 2.48B

USD 40.65B

USD 186.42M

USD 965.32M

USD 29.4M

普通股股本

USD 132.38M

170.7

USD 161.14M

USD 1.1B

销售和管理费用

USD 285.06M

USD 82.72M

贸易债权人

USD 115.72M

应收帐款人

USD 777.57M

	利息收入	更改		日
Acadia Pharmaceuticals	USD 8.25M		1M	2025-09
Agios Pharmaceuticals	USD 13.37M		1.14M	2025-09
Alnylam Pharmaceuticals	USD 28.68M		1.19M	2025-09
Arrowhead Research	USD 9.05M		1.97M	2025-09
BioCryst Pharmaceuticals	USD -0.13		3.59M	2024-12
BioMarin Pharmaceutical	USD 17.85M		973K	2025-09
Incyte	USD 30.75M		3.97M	2025-12
Ionis Pharmaceuticals	USD -0.66		0.29	2024-12
Moderna	USD 73M		8M	2025-09
Regeneron Pharmaceuticals	USD 175.1M		300K	2025-09
Sanofi	EUR 114M		38M	2025-09
Sarepta Therapeutics	USD 8.38M		1.24M	2025-09
Takeda	JPY 87.87B		43.48B	2025-12
Tectonic Therapeutic	USD 1.74M		217K	2024-12
Ultragenyx Pharmaceutical	USD 5.86M		69K	2025-09
Vertex Pharmaceuticals	USD 125.7M		3.3M	2025-09
Xencor	USD 6.54M		710K	2025-09